Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma

References

• Swerdlow SH, Campo E, Harris NL, . WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
   Google Scholar
• Howlader N, Noone AM, Krapcho M, . SEER cancer statistics review 1975–2008. Bethesda, MD: National Cancer Institute; 2011.
   Google Scholar
• Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2008;23:3–9.
   PubMed Web of Science ®Google Scholar
• Liebisch P, Dohner H. Cytogenetics and molecular cytogenetics in multiple myeloma. Eur J Cancer 2006;42:1520–1529.
   PubMed Web of Science ®Google Scholar
• Fonseca R, Barlogie B, Bataille R, . Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004;64:1546–1558.
   PubMedGoogle Scholar
• Shaughnessy JD Jr, Barlogie B. Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling. Immunol Rev 2003;194:140–163.
   PubMed Web of Science ®Google Scholar
• Terpos E, Eleutherakis-Papaiakovou V, Dimopoulos MA. Clinical implications of chromosomal abnormalities in multiple myeloma. Leuk Lymphoma 2006;47:803–814.
   PubMed Web of Science ®Google Scholar
• Zandecki M, Lai JL, Facon T. Multiple myeloma: almost all patients are cytogenetically abnormal. Br J Haematol 1996;94:217–227.
   PubMed Web of Science ®Google Scholar
• Pozdnyakova O, Crowley-Larsen P, Zota V, . Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment. Cancer Genet Cytogenet 2009;189:112–117.
   PubMed Web of Science ®Google Scholar
• Nickenig C, Lang NK, Schoch C, . New insights into the biology of multiple myeloma using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level. Ann Hematol 2001;80:662–668.
   PubMed Web of Science ®Google Scholar
• Tai YT, Teoh G, Shima Y, . Isolation and characterization of human multiple myeloma cell enriched populations. J Immunol Methods 2000;235:11–19.
   PubMed Web of Science ®Google Scholar
• Draube A, Pfister R, Vockerodt M, . Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement. Ann Hematol 2001;80:83–89.
   PubMed Web of Science ®Google Scholar
• Wuilleme S, Robillard N, Lode L, . Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma. Leukemia 2005;19:275–278.
   PubMed Web of Science ®Google Scholar
• Lin P, Owens R, Tricot G, . Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004;121: 482–488.
   PubMed Web of Science ®Google Scholar
• Schmidt-Hieber M, Perez-Andres M, Paiva B, . CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features. Haematologica 2011;96:328–332.
   PubMed Web of Science ®Google Scholar
• Mateo G, Montalban MA, Vidriales MB, . Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J Clin Oncol 2008;26:2737–2744.
   PubMed Web of Science ®Google Scholar
• Sahara N, Takeshita A, Shigeno K, . Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma. Br J Haematol 2002;117:882–885.
   PubMed Web of Science ®Google Scholar
• Nadav L, Katz BZ, Baron S, . Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration. Br J Haematol 2006;133:530–532.
   PubMed Web of Science ®Google Scholar
• Hideshima T, Bergsagel PL, Kuehl WM, . Advances in biology of multiple myeloma: clinical applications. Blood 2004;104:607–618.
   PubMed Web of Science ®Google Scholar
• Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 2005;23: 6333–6338.
   PubMed Web of Science ®Google Scholar
• Bergsagel PL, Kuehl WM. Chromosome translocations in multiple myeloma. Oncogene 2001;20:5611–5622.
   PubMed Web of Science ®Google Scholar
• Mateo G, Castellanos M, Rasillo A, . Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res 2005;11:3661–3667.
   PubMed Web of Science ®Google Scholar
• Bataille R, Pellat-Deceunynck C, Robillard N, . CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis. Leuk Res 2008;32:379–382.
   PubMed Web of Science ®Google Scholar
• Zhan F, Huang Y, Colla S, . The molecular classification of multiple myeloma. Blood 2006;108:2020–2028.
   PubMed Web of Science ®Google Scholar
• Sawyer JR. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Cancer Genet 2011;204: 3–12.
   PubMed Web of Science ®Google Scholar
• Bataille R, Jego G, Robillard N, . The phenotype of normal, reactive and malignant plasma cells. Identification of “many and multiple myelomas” and of new targets for myeloma therapy. Haematologica 2006;91:1234–1240.
   PubMed Web of Science ®Google Scholar
• Ocqueteau M, Orfao A, Garcia-Sanz R, . Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells. Br J Haematol 1996;95:489–493.
   PubMed Web of Science ®Google Scholar